Tag: therapy

Phil McDermott Appointed co-CEO of REVIV a Global Leader in IV Therapy

AETOSWire
Phil McDermott Appointed co-CEO of REVIV a Global Leader in IV Therapy

LONDON — REVIV Global, a world leading IV Drip Therapy company, today announces the appointment of Phil McDermott as co-CEO. With over 15 years of tech industry experience, McDermott joins REVIV to steer its growth and propel the advancement of its technology for personalized and precision nutrition. On this key appointment REVIV CEO and Founder, Sarah Lomas, says: “We are excited to have Phil onboard as co-CEO. His extensive tech background and proven success in driving growth and innovation make him a great fit for the role. Phil’s leadership and…

. 

Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

AETOSWire
Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

WARREN, N.J. — Tevogen Bio today announced positive topline results from its Proof-of-Concept (POC) clinical trial designed to evaluate the safety and feasibility of TVGN 489, the company’s first clinical product of its precision T Cell therapy platform, for the treatment of acute high-risk COVID-19 patients. TVGN 489 is a genetically unmodified, off-the-shelf, allogeneic cytotoxic CD8+ T lymphocyte (CTL) product with precise targets across the SARS-CoV-2 genome, not just the Spike protein. To date, TVGN 489 targets, identified early in the pandemic, persist in the most recent SARS-CoV-2 variants. The open label comparative trial…

. 

The Royal Marsden Private Care to Showcase World-leading Blood Cancer Therapy at Arab Health 2023

NewsVoir
مستشفى رويال مارسدن للرعاية الخاصة يستعرض علاج سرطان الدم الرائد عالميًا في معرض آراب هيلث 2023

Dubai, United Arab Emirates Joining the Harley Street Medical Area (HSMA) stand at Arab Health 2023, The Royal Marsden Private Care will be highlighting one of its latest research-led cancer treatments, CAR T-cell therapy, along with its expertise in treating blood cancers. CAR T-cell therapy is a new form of immunotherapy that uses the body’s own natural immune system to destroy cancer cells. In some cases, it has cured people when all other conventional treatments have failed. It works by taking a patient’s white blood cells (T cells) that help to protect…

Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis

AETOSWire
Tevogen Bio to Develop T Cell Therapies for Treatment of Epstein-Barr Virus Related Cancers and Multiple Sclerosis

WARREN, N.J.: Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in oncology, neurology, and virology today announced its intention to study potential therapeutic use of its allogeneic genetically unmodified precision T cell technology in multiple sclerosis (MS) by developing Epstein-Barr virus (EBV) specific CD8+ cytotoxic T lymphocytes (CTL). These CTLs will also be studied for the potential use in EBV-related cancers, such as nasopharyngeal carcinoma and certain lymphomas. “Recent studies on MS have suggested a probable link between infection with EBV and later onset…

Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

AETOSWire
Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID

WARREN, N.J.: Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in oncology, neurology, and virology announced today its intention to study potential therapeutic use of its investigational COVID-19 T cell therapy, TVGN-489, in Long COVID. The finding that none of the patients in the TVGN 489 Proof-of-Concept (POC) trial, treated for their initial COVID infection, developed Long COVID to date is leading Tevogen to explore the potential of TVGN 489 to also treat Long COVID. “I’m greatly encouraged by the POC trial experience of…

Premium Hair Care Therapy this summer with Vatika Ayurveda

DGN
“ڨاتيكا أيورفيدا” ما تحتاجينه هذا الصيف لعناية فائقة بالشعر

DUBAI, United Arab Emirates – Dry, frizzy, brittle hair that lacks lustre – a common complaint of most girls these days and come summer, these hair woes only heighten. Story of every hair type! Yes! Over time, our lifestyle has changed, and so has our hair care routine. The use of hair styling products, hair colour and hair treatments have increased while the quality and frequency of our hair care routine has reduced. Heat, chemicals, and various treatments that stress the tresses supersede terms like natural, organic, home ingredients. It’s…